SRP9 and cancer: Furthermore, targeting the noncanonical role of SRP9/14 in SGs formation and disassembly could be a potential therapeutic strategy for the treatment of many human diseases where SGs are mainly involved, such as pathogenesis of neurodegenerative diseases, viral infection, aging and cancers (Wang et al., 2020).